{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:50:09Z","timestamp":1769500209640,"version":"3.49.0"},"reference-count":17,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T00:00:00Z","timestamp":1447200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1002\/dta.1893","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T22:20:48Z","timestamp":1447280448000},"page":"869-874","source":"Crossref","is-referenced-by-count":16,"title":["Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysis"],"prefix":"10.1002","volume":"8","author":[{"given":"Masato","family":"Okano","sequence":"first","affiliation":[{"name":"Anti\u2010Doping Laboratory LSI Medience Corporation  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry\/Center for Preventive Doping Research German Sport University Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Anti\u2010Doping Laboratory LSI Medience Corporation  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Anti\u2010Doping Laboratory LSI Medience Corporation  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,11,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2014-093526"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2006.028027"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199712000-00007"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.5.857"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1755"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1680"},{"key":"e_1_2_6_8_1","unstructured":"World Anti\u2010Doping Agency(2013).2014 Prohibited list\u2013Summary of major modifications and explanatory notes. Available at: https:\/\/wada\u2010main\u2010prod.s3.amazonaws.com\/resources\/files\/WADA\u2010Summary\u2010Modifications\u2010Explanatory\u2010Note\u20102014\u2010EN.pdf [25 April 2015]."},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1734"},{"key":"e_1_2_6_10_1","unstructured":"World Anti\u2010Doping Agency(2014).2015 Prohibited list\u2013Summary of major modifications and explanatory notes. Available at: https:\/\/wada\u2010main\u2010prod.s3.amazonaws.com\/resources\/files\/wada\u20102015\u2010prohibited\u2010list\u2010summary\u2010of\u2010modifications\u2010en.pdf [25 April 2015]."},{"key":"e_1_2_6_11_1","unstructured":"World Anti\u2010Doping Agency(2014).The World Anti\u2010Doping Code. The 2015 Prohibited List. International Standard Montreal. Available at: https:\/\/wada\u2010main\u2010prod.s3.amazonaws.com\/resources\/files\/wada\u20102015\u2010prohibited\u2010list\u2010en.pdf [25 April 2015]."},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.48.241"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000357209"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1255\/ejms.1328"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi1947.115.2_120"},{"key":"e_1_2_6_16_1","first-page":"4663","article-title":"Metabolism of lomerizine hydrochloride in human","volume":"22","author":"Awata N.","year":"1994","journal-title":"Jpn Pharmacol Ther"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2013.12.026"},{"key":"e_1_2_6_18_1","unstructured":"World Anti\u2010Doping Agency(2010).Identification criteria for qualitative assays incorporating column chromatography and mass spectrometry. WADA Technical Document \u2013 TD2010IDCR Montreal. Available:https:\/\/wada\u2010main\u2010prod.s3.amazonaws.com\/resources\/files\/WADA_TD2010IDCRv1.0_Identification%20Criteria%20for%20Qualitative%20Assays_May%2008%202010_EN.doc.pdf[25 April 2015]."}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdta.1893","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.1893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T10:34:03Z","timestamp":1760351643000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.1893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,11]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1002\/dta.1893"],"URL":"https:\/\/doi.org\/10.1002\/dta.1893","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,11]]}}}